Sign inGet started

Stoppel Laura

Insider CIK 1865119 · ABOS Director · ARTV Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2026-06-032026-06-0553,250— $053,250SEC↗
ABOS Acumen Pharmaceuticals, In A Award2026-06-032026-06-0535,500— $048,300SEC↗
ARTV Artiva Biotherapeutics, In A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2025-06-042025-06-0519,500— $019,500SEC↗
ABOS Acumen Pharmaceuticals, In A Award2025-06-042025-06-0512,800— $012,800SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2024-06-102024-06-1025,000— $025,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2023-06-062023-06-0725,000— $025,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2022-06-152022-06-1725,000— $025,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2021-06-302021-07-0234,000— $034,000SEC↗